Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA VINCI: Aflibercept for Diabetic Macular Edema
NCT00789477Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of aflibercept in diabetic macular edema (DME), sponsored by Regeneron Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00789477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789477.